All articles
Developing an HEOR evidence generation strategy to support product launch
Examining the association of social determinants of health with outcomes in patients with pulmonary arterial hypertension
Applying patient preferences in treatment for triple negative breast cancer to value assessment
Case Study
MFP effectuation: Preventing a duplicate 340B discount
Federal and state policy
Webinar: After the midterms: What do the results mean for drug pricing, Medicare, and public health?
How MFN pricing in the final GLOBE Model will affect beneficiary OOP costs
Women's health
Women’s Health Initiative
Coverage and payment
Medicare’s proposed IPCI and modifier 25 changes could reduce dermatology reimbursement
Wendy Jory, PhD, MBA, global and US pricing and market access leader, joins Avalere Health as Senior Vice President, Market Access
Drug pricing and affordability
Beyond Medicare: How Part B drug negotiation may reshape commercial reimbursement